A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction

Trial Profile

A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Valsartan (Primary)
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Acronyms VALIDD
  • Most Recent Events

    • 07 Nov 2011 Actual end date (June 2006) added as reported by ClinicalTrials.gov.
    • 25 Mar 2007 Results data have been presented.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top